149 related articles for article (PubMed ID: 32861282)
41. "Triple hit" SOX11
Jain P; Tang G; Li S; Wang M
Am J Hematol; 2021 Jan; 96(1):165-166. PubMed ID: 32356355
[No Abstract] [Full Text] [Related]
42. ROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy.
Chen Z; Teo AE; McCarty N
Clin Cancer Res; 2016 Jan; 22(1):187-99. PubMed ID: 26350264
[TBL] [Abstract][Full Text] [Related]
43. Results from the Belgian mantle cell lymphoma registry.
Vergote V; Janssens A; André M; Bonnet C; Van Hende V; Van Den Neste E; Van Eygen K; Maerevoet M; Pranger D; Schroyens W; Debussche S; Maertens V; Beel K; Lemmens J; Caron C; Delrieu V; Van Den Broeck I; Vanstraelen G; Jacquy C; Schauvlieghe L; De Samblanx H; Madoe V; Meers S; Boulet D; Verhoef G; Van Hoof A
Acta Clin Belg; 2017 Jun; 72(3):172-178. PubMed ID: 28222652
[TBL] [Abstract][Full Text] [Related]
44. Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT).
Rosenbluth BD; Yahalom J
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1185-91. PubMed ID: 16682133
[TBL] [Abstract][Full Text] [Related]
45. Synchronous mantle cell lymphoma and prostate adenocarcinoma-is it just a coincidence?
Petković I; Stojnev S; Krstić M; Pejčić I; Vrbić S
Vojnosanit Pregl; 2016 Nov; 73(11):1072-5. PubMed ID: 29341562
[TBL] [Abstract][Full Text] [Related]
46. Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma.
Joao C; Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Gastineau DA; Markovic SN
Bone Marrow Transplant; 2006 May; 37(9):865-71. PubMed ID: 16532015
[TBL] [Abstract][Full Text] [Related]
47. Leukemic Non-nodal Mantle Cell Lymphoma: Diagnosis and Treatment.
Jain AG; Chang CC; Ahmad S; Mori S
Curr Treat Options Oncol; 2019 Nov; 20(12):85. PubMed ID: 31776787
[TBL] [Abstract][Full Text] [Related]
48. Mantle Cell Lymphoma Involving Skin: A Clinicopathologic Study of 37 Cases.
Kim DH; Medeiros LJ; Aung PP; Young KH; Miranda RN; Ok CY
Am J Surg Pathol; 2019 Oct; 43(10):1421-1428. PubMed ID: 31219818
[TBL] [Abstract][Full Text] [Related]
49. The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patients.
Dreger P; Martin S; Kuse R; Sonnen R; Glass B; Kröger N; Parwaresch R; Kneba M; Schmitz N; Haas R
Hematol J; 2000; 1(2):87-94. PubMed ID: 11920175
[TBL] [Abstract][Full Text] [Related]
50. Primary cutaneous mantle cell lymphoma with blastic features: report of a rare case with special reference to staging and effectiveness of chemotherapy.
Lynch DW; Verma R; Larson E; Geis MC; Jassim AD
J Cutan Pathol; 2012 Apr; 39(4):449-53. PubMed ID: 22121909
[TBL] [Abstract][Full Text] [Related]
51. Diffuse aggressive lymphoma.
Fisher RI; Miller TP; O'Connor OA
Hematology Am Soc Hematol Educ Program; 2004; ():221-36. PubMed ID: 15561685
[TBL] [Abstract][Full Text] [Related]
52. Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen).
Gianni AM; Magni M; Martelli M; Di Nicola M; Carlo-Stella C; Pilotti S; Rambaldi A; Cortelazzo S; Patti C; Parvis G; Benedetti F; Capria S; Corradini P; Tarella C; Barbui T
Blood; 2003 Jul; 102(2):749-55. PubMed ID: 12663455
[TBL] [Abstract][Full Text] [Related]
53. "In situ-like" mantle cell lymphoma: a report of two cases.
Richard P; Vassallo J; Valmary S; Missoury R; Delsol G; Brousset P
J Clin Pathol; 2006 Sep; 59(9):995-6. PubMed ID: 16935977
[TBL] [Abstract][Full Text] [Related]
54. Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma.
William BM; Allen MS; Loberiza FR; Bociek RG; Bierman PJ; Armitage JO; Vose JM
Biol Blood Marrow Transplant; 2014 Apr; 20(4):536-42. PubMed ID: 24434781
[TBL] [Abstract][Full Text] [Related]
55. What is the role of 18F-fluorodeoxyglucose positron emission tomography in mantle cell lymphoma?
Gill S; Hicks RJ; Seymour JF
Leuk Lymphoma; 2008 Sep; 49(9):1653-6. PubMed ID: 18798097
[No Abstract] [Full Text] [Related]
56. New strategies in the treatment of mantle cell lymphoma.
Deng C; Lee S; O'Connor OA
Clin Cancer Res; 2012 Jul; 18(13):3499-508. PubMed ID: 22700864
[TBL] [Abstract][Full Text] [Related]
57. Emerging therapy for the treatment of mantle cell lymphoma.
Rajguru S; Kahl BS
J Natl Compr Canc Netw; 2014 Sep; 12(9):1311-8; quiz 1318. PubMed ID: 25190697
[TBL] [Abstract][Full Text] [Related]
58. Limited-stage mantle-cell lymphoma.
Leitch HA; Gascoyne RD; Chhanabhai M; Voss NJ; Klasa R; Connors JM
Ann Oncol; 2003 Oct; 14(10):1555-61. PubMed ID: 14504058
[TBL] [Abstract][Full Text] [Related]
59. In situ mantle cell lymphoma in the nasopharynx.
Koletsa T; Markou K; Ouzounidou S; Tsiompanou F; Karkavelas G; Kostopoulos I
Head Neck; 2013 Nov; 35(11):E333-7. PubMed ID: 23280758
[TBL] [Abstract][Full Text] [Related]
60. Case Study: Rare Case of Mantle Cell Lymphoma With Extranodal Involvement in the Foot.
Fu P; Mercado D; Malezhik V; Mannan AASR
J Foot Ankle Surg; 2017; 56(5):1104-1108. PubMed ID: 28842094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
